USANA Health Sciences Inc USNA.N, USNA.K is expected to show a rise in quarterly revenue when it reports results on July 22 for the period ending June 30 2025
The Salt Lake City Utah-based company is expected to report a 5.8% increase in revenue to $225.195 million from $212.87 million a year ago, according to the estimate from one analyst, based on LSEG data.
LSEG's mean analyst estimate for USANA Health Sciences Inc is for earnings of 54 cents per share.
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for USANA Health Sciences Inc is $61.00, about 49.8% above its last closing price of $30.63
This summary was machine generated July 18 at 20:21 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)